Table 3.
Frequency of MC in the ELL-DOPA trial (%)
| LD/CD | LD/CD | LD/CD | ||
|---|---|---|---|---|
| |
150 mg |
300 mg |
600 mg |
Placebo |
| dyskinesia |
3.3 |
2.3 |
16.5 |
3.3 |
| wearing off | 16.3 | 18.2 | 29.7 | 13.3 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.